A breast prosthesis of the French brand Poly implants prothèses (PIP) is considered suspicious of causing the occurrence of nine cases of breast cancer and of having caused the death of a woman in France. While the facts are being verified (the Marseille Public Prosecutor's Office has received 2,000 complaints and has opened an investigation), and as a precautionary measure, the health authorities in this country have recommended the carriers of these implants (some 30,000) to be treated. withdraw, because they have been manufactured with a silicone gel not approved for medical use, and there is a risk of rupture, which can have serious consequences for health.

The prostheses were manufactured with a silicone gel not approved for medical use, and there is a risk of rupture, which can have serious consequences for health

In March of last year, defective PIP implants were removed from the market and all affected women were advised to perform regular check-ups to detect any abnormalities early. Many of these prostheses could have been sold in Latin America. In Spain, it is estimated that between 5,000 and 10,000 women may have been operated on with these prostheses, because they were also distributed in our country before being prohibited from being commercialized. Although at the moment no case of cancer has been reported, there have been several cases of women who have suffered the rupture of the prosthesis, and had to undergo a breast reconstruction after the episode.

The Spanish Ministry of Health recommends all those affected to go to the surgeon who operated them to check the status of the prosthesis. For his part, Jaume Masià, president of the Spanish Society of Plastic, Aesthetic and Reconstructive Surgery (SECPRE), ensures that the members of this society are following all indications of the Ministry and the Spanish Agency of Medicines, and advises carriers of these prostheses that are removed if there is any doubt about its possible wear or tear.

Langstein on Implants and Cancer Risk.flv (November 2019).